Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00475007 · ClinicalTrials.gov registry record · NA
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
A NA study of COPD and Emphysema, sponsored by Olympus Corporation of the Americas.
- Completed
- Registry status
- NA
- Development phase
- 277
- Enrollment target
- 20
- Study locations
NCT00475007: Completed NA study of COPD and Emphysema, sponsored by Olympus Corporation of the Americas.
NCT00475007 is a NA study of COPD and Emphysema that has completed, run by Olympus Corporation of the Americas. The registered enrollment target is 277 participants, below the 2,415-participant average among 85 other COPD trials with a reported enrollment target (89% lower). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00475007, a NA study of COPD and Emphysema, has completed, sponsored by Olympus Corporation of the Americas.
- COMPLETED
- Registry status
- NA
- Development phase
- 277 participants
- Enrollment target
- 20
- Study locations
Study Summary
This trial is for men and women between the ages of 40 and 74 who have a confirmed diagnosis of emphysema. The objective of the trial is to determine the safety and effectiveness of the IBV Valve at redirecting airflow from diseased portions of the lung to healthier areas to achieve improvement in disease-related health status.
Interventions
- DEVICE IBV® Valve System
Study Locations (20)
California
- Kaiser Permanente Medical Center - Los Angeles
- University of California Los Angeles (UCLA) - Los Angeles
- Mission Internal Medicine Group - Mission Viejo
- University of California Davis Medical Center - Sacramento
- University of California San Diego - San Diego
Illinois
- University of Chicago - Chicago
- Alexian Brothers Hospital Network - Elk Grove Village
- Southern Illinois University School of Medicine - Springfield
Florida
- University of Florida - Gainesville
- Sarasota Memorial Hospital - Sarasota
New York
- Mount Sinai School of Medicine - New York
- Columbia University Medical Center - New York
Alabama
- University of Alabama at Birmingham - Birmingham
Colorado
- National Jewish Medical & Research Center - Denver
Georgia
- Emory HealthCare - Atlanta
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 277 participants |
| Start Date | 2007-09 |
| Est. Completion | 2017-08 |
| Phase | NA |
What the finished NCT00475007 record still lists
NCT00475007 is an interventional study that assigns participants to a tested intervention. The registered 277 participants enrollment target is mid-sized for trials with a published cap, below the 2,415-participant average among 85 other COPD trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with COPD appearing as the primary indexed condition, and to 1 intervention - of which IBV® Valve System is the first listed.
NCT00475007 names 20 study sites across 12 states, led by California, Illinois, Florida.
Frequently Asked Questions
What is clinical trial NCT00475007 about?
NCT00475007 is a clinical study titled "Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema". This trial is for men and women between the ages of 40 and 74 who have a confirmed diagnosis of emphysema. The objective of the trial is to determine the safety and effectiveness of the IBV Valve at redirecting airflow from diseased portions of the lung to healthier areas to achieve improvement in d...
What is the current status of trial NCT00475007?
This trial is currently completed. It is a NA study. The enrollment target is 277 participants. The study started on 2007-09. Estimated completion is 2017-08.
What conditions does trial NCT00475007 study?
This clinical trial studies the following conditions: COPD, Emphysema.
What interventions are being tested in trial NCT00475007?
The interventions under investigation include: IBV® Valve System (DEVICE).
Who is sponsoring clinical trial NCT00475007?
This trial is sponsored by Olympus Corporation of the Americas, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00475007 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00475007's enrollment target sits among peer trials
277 26th of 85 higher than 60 of 85 other COPD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
The Reducing REVISITS Study: A Cluster RCT
RECRUITING · NA
-
The Effect of a Technology-Mediated Integrated Walking and Tai Chi Intervention on Physical Function in Veterans With COPD and Chronic Musculoskeletal Pain
RECRUITING · NA
-
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05818683 · 277 participants · Phase 1
A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer
- NCT06789913 · 277 participants · Phase 2
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation
- NCT04586959 · 278 participants · NA
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
- NCT05010148 · 278 participants · Phase 3
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia